Active BE 0789.690.856Private limited company

FaceX

Arkenvest 10 ·1500 Halle, Belgium· 3 yrs active

Sector: Human health (86101)

Conclusion Checked

The computed 12-month bankruptcy probability of FaceX is 0.2% (very low). The 2024 annual accounts show equity of €793k and a net result of €444k. Its solvency ranks better than 62% of 6539 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Key figures

Equity	€793k
Net result	€444k
Better than sector	62%
Active	3 yrs

Snowflake analysis 5 axes · computed by Checked

94 / 100

Exceptional profile, strong across almost every axis.

Health 100

Profitability 100

Solvency 100

Growth 78

Stability 94

Bankruptcy probability (12 mo) Checked model v1 · free

0.2% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +Annual accounts: healthy financial profile −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based

0 / 100

Low risk

Trust signals 3 signals

More than 3 years active

Founded in 2022, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.

Administratively compliant

No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags 0 events

No administrative flags

Health barometer FY 2024 · computed

100 / 100 Excellent

050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →

Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Financial overview2 NBB filings

Annual accounts filed on 27-08-2025 with the NBB · fiscal year 2024 · micro

Operating resultNet result

Sector comparison

Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	75.3%	66.7%	better than 62% of 6539 sector peers
Net result	€444k	€46k	better than 95% of 6533 sector peers
Equity	€793k	€79k	better than 95% of 6539 sector peers
Gross operating margin	€599k	€78k	better than 95% of 6541 sector peers
Total assets	€1.05M	€154k	better than 95% of 6542 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

EBITDA

€598k

+28.6% far above sector median

Net profit

€444k

+27.6% far above sector median

Cash flow

€456k

+28.5% far above sector median

Total assets

€1.05M

+127.9% +227% vs sector

Equity

€793k

+126.6% +287% vs sector

Working capital

€747k

+153.8% +277% vs sector

Staff costs

€46k

- 23-24

Income taxes

€143k

+29.1% +208% vs sector

Debt

€261k

+132.0% +157% vs sector

Debt ≤ 1y

€258k

+129.6% +226% vs sector

Current ratio

3.90

+7.6% +21% vs sector

Quick ratio

3.90

+7.6% +21% vs sector

Solvency

75.3%

-0.6% +9% vs sector

Debt / equity

0.33

+2.4% -26% vs sector

ROE

56.0%

-43.7% +12% vs sector

ROA

42.1%

-44.0% -5% vs sector

Interest coverage

4099.93

+39.9% far above sector median

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2024
Revenue	-
EBITDA	€598k
Net profit	€444k
Cash flow	€456k
Staff costs	-
Income taxes	€143k
Dividends	-
Total assets	€1.05M
Equity	€793k
Debt	€261k
of which ≤ 1y	€258k
of which > 1y	-
Working capital	€747k
Employees (FTE)	-

Ratios (computed)

	2024
Current ratio	3.90
Quick ratio	3.90
Working capital ratio	70.9%
Solvency	75.3%
Debt / equity	0.33
Long-term debt ratio	-
Interest coverage	4099.93
Gross margin	-
Net margin	-
ROA	42.1%
ROE	56.0%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2024

Assets

Fixed assets €48k · 4.6% Current assets €1.01M · 95.4%

Equity & liabilities

Equity €793k · 75.3% Debt €261k · 24.7%

Full annual accounts

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.05M
Fixed assets	21/28	€48k
Tangible fixed assets	22/27	€48k
Current assets	29/58	€1.01M
Amounts receivable within one year	40/41	€30k
Investments	50/53	€880k
Cash & bank	54/58	€95k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.05M
Equity	10/15	€793k
Contributions / capital	10/11	€2k
Accumulated profits (losses)	14	€791k
Amounts payable	17/49	€261k
Amounts payable within one year	42/48	€258k
Trade debts payable within one year	44	€3k
Income statement
Gross operating margin	9900	€599k
Operating result	9901	€586k
Financial charges	65	€146
Result before taxes	9903	€586k
Income taxes	67/77	€143k
Net result for the period	9904	€444k
Result to be appropriated	9905	€444k

You're seeing the latest fiscal year only. Unlock 1 prior year (figures + ratios) with a paid plan. See plans →

Ratios computed by Checked.

Legal Structure

NACE primary	Human health(86101)
Legal form	Private limited company(610)
Incorporation	16-08-2022
Status	Active
Postal code	1500

Establishment units 1 location

FaceX

Arkenvest 10, 1500 HalleActiviteiten van medisch specialisten

since 20222.334.771.687

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
23027G0625/00G000	Flanders	1,426 m²	1 · 1,106 m²	12.6 m · 3 fl.

Methodology

via registered seat: 1

1 of 1 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Updates 2 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2025

27-08-2025

NBB filing Annual accounts filed

fiscal year 2024 · micro

2024

26-08-2024

NBB filing Annual accounts filed

fiscal year 2023 · micro

Credit advice verdict per customer and amount

AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon

AI-generated from Checked data; indicative, not legal or investment advice.

Company registry (CBE) Crossroads Bank

Activities

Activiteiten van algemene ziekenhuizen, muv geriatrische en gespecialiseerde ziekenhuizen86101Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen68203

Primary activity highlighted.

Names & trade names

Legal nameNL

FaceX

Registered office

Arkenvest 10 bus 41

1500 Halle, Belgium

Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.

Similar companies Same NACE

SORELECO BE 0755.514.687 · Ukkel

Dokter Prud’homme Patrick BE 0781.941.843 · Eeklo

Behrmed BE 0675.805.730 · Brussel

Dr. M. Veys BE 0765.264.573 · Brugge

SANCHEZTHESIA BE 0751.634.984 · Etterbeek